The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity
Open accessAbstract
ATP-dependent DNA supercoiling catalyzed by Escherichia coli DNA gyrase was inhibited by oxolinic acid, a compound similar to but more potent than nalidixic acid and a known inhibitor of DNA replication in E. coli . The supercoiling activity of DNA gyrase purified from nalidixic acid-resistant mutant ( nalA R ) bacteria was resistant to oxolinic acid. Thus, the nalA locus is responsible for a second component needed for DNA gyrase activity in addition to the component determined by the previously described locus for resistance to novobiocin and coumermycin ( cou ). Supercoiling of λ DNA in E. coli cells was likewise inhibited by oxolinic acid, but was resistant in the nalA R mutant. The inhibition by oxolinic acid of colicin E1 plasmid DNA synthesis in a cell-free system was largely relieved by adding resistant DNA gyrase. In the absence of ATP, DNA gyrase preparations relaxed supercoiled DNA; this activity was also inhibited by oxolinic acid, but not by novobiocin. It appears that the oxolinic acid-sensitive component of DNA gyrase is involved in the nicking-closing activity required in the supercoiling reaction. In the presence of oxolinic acid, DNA gyrase forms a complex with DNA, which can be activated by later treatment with sodium dodecyl sulfate and a protease to produce double-strand breaks in the DNA. This process has some similarities to the known properties of relaxation complexes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clewell, D. B., & Helinski, D. R. (1969) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.62.4.1159 · Cited by 1,820
DNA gyrase: an enzyme that introduces superhelical turns into DNA.
Gellert, M., Mizuuchi, K., O'Dea, M. H., & Nash, H. A. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.3872 · Cited by 1,204
Self-citationInteraction between DNA and an Escherichia coli protein ω
Wang, J. C. (1971) · Journal of Molecular Biology · doi:10.1016/0022-2836(71)90334-2 · Cited by 786
Sugino, A., Peebles, C. L., Kreuzer, K. N., & Cozzarelli, N. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4767 · Cited by 784
Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
Gellert, M., O'Dea, M. H., Itoh, T., & Tomizawa, J. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.12.4474 · Cited by 727
Self-citationGenetic Transformation in Escherichia coli K12
Cosloy, S. D., & Oishi, M. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.1.84 · Cited by 150
Replication of Colicin E1 Plasmid DNA in Cell Extracts
Sakakibara, Y., & Tomizawa, J.-I. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.3.802 · Cited by 141
Self-citation
Cited by
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Sampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Biochemistry of homologous recombination in Escherichia coli
Kowalczykowski, S. C., Dixon, D. A., Eggleston, A. K., Lauder, S. D., & Rehrauer, W. M. (1994) · Microbiological Reviews · doi:10.1128/mr.58.3.401-465.1994 · Cited by 1,250
Linkage map of Escherichia coli K-12, edition 6
Bachmann, B., & Low, K. B. (1980) · Microbiological Reviews · doi:10.1128/mmbr.44.1.1-56.1980 · Cited by 938
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., & Robicsek, A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-09 · Cited by 928
Pham, T. D. M., Ziora, Z. M., & Blaskovich, M. A. T. (2019) · MedChemComm · doi:10.1039/c9md00120d · Cited by 785
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M., & Nakamura, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1647 · Cited by 777
Histonelike proteins of bacteria
Drlica, K., & Rouvière‐Yaniv, J. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.3.301-319.1987 · Cited by 769
DNA Gyrase: Structure and Function
Reece, R. J., & Maxwell, A. (1991) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239109114072 · Cited by 728
Ruiz, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg222 · Cited by 711
DNA Gyrase and the Supercoiling of DNA
Cozzarelli, N. R. (1980) · Science · doi:10.1126/science.6243420 · Cited by 711
Exploiting bacterial DNA gyrase as a drug target: current state and perspectives
Collin, F., Karkare, S., & Maxwell, A. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3557-z · Cited by 606
Quinolones: from antibiotics to autoinducers
Heeb, S., Fletcher, M. P., Chhabra, S. R., Diggle, S. P., Williams, P., & Cámara, M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00247.x · Cited by 595
Quinolone-Mediated Bacterial Death
Drlica, K., Malik, M., Kerns, R. J., & Zhao, X. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01617-06 · Cited by 570
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., & Nakamura, S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1271 · Cited by 570
The quinolones: decades of development and use
Emmerson, A. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg208 · Cited by 531
Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes
Bernard, P., & Couturier, M. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90629-x · Cited by 510
Mechanisms of fluoroquinolone resistance
Hooper, D. C. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0068 · Cited by 488
Topoisomerases as anticancer targets
Delgado, J. L., Hsieh, C.-M., Chan, N.-L., & Hiasa, H. (2018) · Biochemical Journal · doi:10.1042/bcj20160583 · Cited by 481
Yoshida, H., Bogaki, M., Nakamura, S., Ubukata, K., & Konno, M. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.12.6942-6949.1990 · Cited by 479
Plasmid-Mediated Quinolone Resistance
Jacoby, G. A., Strahilevitz, J., & Hooper, D. C. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.plas-0006-2013 · Cited by 479
Regulation of the genes for E. coli DNA gyrase: Homeostatic control of DNA supercoiling
Menzel, R., & Gellert, M. (1983) · Cell · doi:10.1016/0092-8674(83)90140-x · Cited by 466
Self-citationEscherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes
Dinardo, S., Voelkel, K. A., Sternglanz, R., Reynolds, A. E., & Wright, A. (1982) · Cell · doi:10.1016/0092-8674(82)90403-2 · Cited by 446
Topological domain structure of the Escherichia coli chromosome
Postow, L., Hardy, C. D., Arsuaga, J., & Cozzarelli, N. R. (2004) · Genes & Development · doi:10.1101/gad.1207504 · Cited by 439
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae
Pan, X. S., Ambler, J., Mehtar, S., & Fisher, L. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2321 · Cited by 437
The Quinolones: Past, Present, and Future
Andriole, V. T. (2005) · Clinical Infectious Diseases · doi:10.1086/428051 · Cited by 428
Shen, L. L., Mitscher, L. A., Sharma, P. N., O'Donnell, T. J., Chu, D. W. T., Cooper, C. S., Rosen, T., & Pernet, A. G. (1989) · Biochemistry · doi:10.1021/bi00435a039 · Cited by 413
Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance
Bush, N. G., Diez-Santos, I., Abbott, L. R., & Maxwell, A. (2020) · Molecules · doi:10.3390/molecules25235662 · Cited by 413
Levine, C., Hiasa, H., & Marians, K. J. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00126-2 · Cited by 391
Topoisomerase IV is a target of quinolones in Escherichia coli.
Khodursky, A. B., Zechiedrich, E. L., & Cozzarelli, N. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11801 · Cited by 378
Quinolones: Action and Resistance Updated
Drlica, K., Hiasa, H., Kerns, R., Malik, M., Mustaev, A., & Zhao, X. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789630947 · Cited by 376
Control of bacterial DNA supercoiling
Drlica, K. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb01486.x · Cited by 373
Everett, M. J., Jin, Y. F., Ricci, V, & Piddock, L. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2380 · Cited by 365
Kreuzer, K. N., & Cozzarelli, N. R. (1979) · Journal of Bacteriology · doi:10.1128/jb.140.2.424-435.1979 · Cited by 337
A Sign Inversion Mechanism for Enzymatic Supercoiling of DNA
Brown, P. O., & Cozzarelli, N. R. (1979) · Science · doi:10.1126/science.227059 · Cited by 332
Genomic transcriptional response to loss of chromosomal supercoiling in Escherichia coli
Peter, B. J., Arsuaga, J., Breier, A. M., Khodursky, A. B., Brown, P. O., & Cozzarelli, N. R. (2004) · Genome Biology · doi:10.1186/gb-2004-5-11-r87 · Cited by 323
DNA Topoisomerases: Enzymes That Control DNA Conformation
Vosberg, H.-P. (1985) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-70227-3_2 · Cited by 321
Multi-targeting by monotherapeutic antibacterials
Silver, L. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2202 · Cited by 311
Ali, J. A., Jackson, A. P., Howells, A. J., & Maxwell, A. (1993) · Biochemistry · doi:10.1021/bi00061a033 · Cited by 303
New Directions in Antibacterial Research
Chu, D. T. W., Plattner, J. J., & Katz, L. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960294s · Cited by 298
DNA transport by a type II DNA topoisomerase: Evidence in favor of a two-gate mechanism
Roca, J., & Wang, J. C. (1994) · Cell · doi:10.1016/0092-8674(94)90222-4 · Cited by 288
ATP-dependent DNA topoisomerase from D. melanogaster reversibly catenates duplex DNA rings
Hsieh, T.-S., & Brutlag, D. (1980) · Cell · doi:10.1016/0092-8674(80)90119-1 · Cited by 286
Double strand DNA cleavage by type II DNA topoisomerase from Drosophila melanogaster.
Sander, M., & Hsieh, T. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82081-x · Cited by 285
Sternglanz, R., DiNardo, S., Voelkel, K. A., Nishimura, Y., Hirota, Y., Becherer, K., Zumstein, L., & Wang, J. C. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.2747 · Cited by 285
Structure-activity relationships of the fluoroquinolones
Chu, D. T., & Fernandes, P. B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.2.131 · Cited by 284
Wang, Y., Huang, W. M., & Taylor, D. E. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.457 · Cited by 280
Interactions of bacteriophage and host macromolecules in the growth of bacteriophage lambda
Friedman, D. I., Olson, E. R., Georgopoulos, C. P., Tilly, K., Herskowitz, I., & Banuett, F. (1984) · Microbiological Reviews · doi:10.1128/mmbr.48.4.299-325.1984 · Cited by 279
Gottesman, S., Trisler, P., & Torres-Cabassa, A. (1985) · Journal of Bacteriology · doi:10.1128/jb.162.3.1111-1119.1985 · Cited by 270
The interaction between coumarin drugs and DNA gyrase
Maxwell, A. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01728.x · Cited by 264
Liu, L. F., Liu, C.-C., & Alberts, B. M. (1979) · Nature · doi:10.1038/281456a0 · Cited by 264
Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli
Yamagishi, J.-I., Yoshida, H., Yamayoshi, M., & Nakamura, S. (1986) · Molecular and General Genetics MGG · doi:10.1007/bf00331012 · Cited by 263
Peng, H., & Marians, K. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80551-1 · Cited by 261
Interfacial inhibitors: targeting macromolecular complexes
Pommier, Y., & Marchand, C. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3404 · Cited by 259
Mechanistic Aspects of DNA Topoisomerases
Maxwell, A., & Gellert, M. (1986) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60526-4 · Cited by 258
Self-citationPurification of subunits of Escherichia coli DNA gyrase and reconstitution of enzymatic activity
Higgins, N. P., Peebles, C. L., Sugino, A., & Cozzarelli, N. R. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.4.1773 · Cited by 257
Type II topoisomerases--inhibitors, repair mechanisms and mutations
Heisig, P. (2009) · Mutagenesis · doi:10.1093/mutage/gep035 · Cited by 63
Metadata
- Authors
- Gellert, M., Mizuuchi, K., O'Dea, M. H., Itoh, T., & Tomizawa, J.-I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1977-11
- Volume
- 74
- Issue
- 11
- Pages
- 4772-4776
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1996007131
- Cited by
- 833
- References
- 7
- FWCI
- 24.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.